Back

Prognostic impact of mineralocorticoid receptor antagonists in patients hospitalized for acute heart failure

1 September 2019 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: Treatment of conundrum in acute heart failure Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hidenori Yaku

National Cerebral & Cardiovascular Center, Suita (Japan)

4 More presentations in this session

Presentation thumbnail
State of the Art - TakoTsubo
Doctor J. Ghadri (Greifswald, DE)
Presentation thumbnail
Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial
Doctor A. Ambrosy (San Francisco, US)
Abstract Slides Video
Presentation thumbnail
A life support based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis ---- a multiple center study
Doctor D. Wang (Nanjing, CN)
Abstract
Presentation thumbnail
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.
Professor D. Morrow (Boston, US)
Slides Video

Access the full session

Session thumbnail
Treatment of conundrum in acute heart failure

The Event

Event poster

ESC Congress 2019

1 September 2019 09:06 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources